Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.82 +0.02 (+2.73%)
As of: Oct 2, 2026 · 9:55 AM EDT

Rani Therapeutics Holdings (RANI) Non-Current Debt (2020 - 2025)

Updated

Rani Therapeutics Holdings' Non-Current Debt was $2.23 million in Q2 2025, down 87.0% from $17.21 million a year earlier and down 62.4% from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Non-Current Debt (2020 - 2025) Analysis & Trends

At the end of FY2024, Non-Current Debt at Rani Therapeutics Holdings came in at $9.61 million, down 60.7% from FY2023.

  • Non-Current Debt shows a four-year compound annual growth rate of 41.3% (FY2020 to FY2024).
  • In earlier years, Non-Current Debt was $24.48 million in FY2023 (-16.0%), $29.15 million in FY2022 and $2.41 million in FY2020.
  • The Q2 2025 figure marks the lowest quarterly Non-Current Debt in data going back to Q4 2020.
  • Compared with a year earlier, Non-Current Debt has declined for seven straight quarters, with an average decline of 32.2% over the last eight quarters.
  • The best year-over-year quarter for Non-Current Debt over five years was Q3 2023 (growth of 99.4%); the worst was Q2 2025 (a decline of 87.0%).
  • Per Business Quant data, RANI's Non-Current Debt in the three quarters before Q2 2025 was $5.92 million (Q1 2025), $9.61 million (Q4 2024) and $13.54 million (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 37.34 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 62.48 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -108.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 23.83 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 2.23 Mn
Mar 31, 2025 5.92 Mn
Dec 31, 2024 9.61 Mn
Sep 30, 2024 13.54 Mn
Jun 30, 2024 17.21 Mn
Mar 31, 2024 20.85 Mn
Dec 31, 2023 24.48 Mn
Sep 30, 2023 28.10 Mn
Jun 30, 2023 29.27 Mn
Mar 31, 2023 29.21 Mn
Dec 31, 2022 29.15 Mn
Sep 30, 2022 14.09 Mn
Dec 31, 2020 2.41 Mn
API Access

Rani Therapeutics Holdings Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=RANI&period=max&api_key=YOUR_API_KEY